Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P240044/S008

Globe Pulsed Field System; Globe Catheter

Kardium, Inc. · Decision date Oct 23, 2026

MEDTECHLEDGER EXPLANATIONP240044/S008

What did the FDA decide?

The FDA record for P240044/S008 describes a 30-Day Notice submitted by Kardium, Inc. for the Globe Pulsed Field System and Globe Catheter, a percutaneous cardiac ablation catheter for atrial fibrillation using irreversible electroporation. The stated change is a modification to the sterilization cycle parameters and the use of a larger maximum sterilization load.

The listed reason is a process change involving the manufacturer, sterilizer, packager or supplier. This supplement sits under the original PMA identifier P240044; the record does not establish the original approval date, prior sterilization settings, or the specific parameter values changed. The statement reports the applicant's stated purpose, not independent evidence of safety or clinical effectiveness, and the decision date in the record is 2026-10-23.

FDA approval order statement

modification to the sterilization cycle parameters and use of a larger maximum sterilization load
Regulatory pathway
PMA supplement
Supplement type
30-Day Notice
Clinical specialty
Cardiovascular
Decision date
Oct 23, 2026
FDA change category
Process Change - Manufacturer/Sterilizer/Packager/Supplier

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
P240044/S008
Regulatory pathway
PMA supplement
Applicant
Kardium, Inc.
Product code
QZI
Decision code
OK30
Decision date
Oct 23, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Percutaneous Cardiac Ablation Catheter for Treatment of Atrial Fibrillation with Irreversible Electroporation.

Applicant
Kardium, Inc.
Product code
QZI
FDA device class
3

For the original device and its historical approval scope, see PMA P240044. Subsequent supplements may change the device or its indications.

FDA decision timeline

  1. P240044 · Original PMA

    Globe Pulsed Field System

  2. P240044/S008 received

    Application receipt date recorded by FDA.

  3. P240044/S008 · FDA decision

    30-Day Notice

  4. P240044/S007 · Related supplement

    Globe Catheter and Globe Pulsed Field System

Timeline entries are records held by MedtechLedger for P240044. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P240044

Product / regulatory recordCompanyPathwayDecision dateSource
Kardium, Inc.PMA approvalAug 27, 2025FDA
Kardium, Inc.PMA supplementOct 27, 2026FDA

Explore the linked device profile

Other records with product code QZI

Product / regulatory recordCompanyPathwayDecision dateSource
Biosense Webster, Inc.PMA supplementNov 3, 2026FDA
Volt PFA SystemP250022/S002
ABBOTT MEDICALPMA supplementOct 15, 2026FDA
Medtronic, Inc.PMA supplementOct 9, 2026FDA
ABBOTT MEDICALPMA supplementOct 8, 2026FDA
ABBOTT MEDICALPMA supplementOct 8, 2026FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Kardium, Inc.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
8518 Glenlyon Pkwy., Unit 155, Burnaby, V5J OB6

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records